Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis
{{output}}
Interferon beta (IFN-β) and glatiramer acetate (GA) are the primary therapeutic immunomodulatory agents that interfere with relapsing-remitting multiple sclerosis (RRMS), and the most commonly-used drugs as well. Induction or aggravation of other immune-media... ...
